These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8052433

  • 1. Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme.
    Almond MK, Tailor D, Marsh FP, Raftery MJ, Cunningham J.
    Nephrol Dial Transplant; 1994; 9(3):270-3. PubMed ID: 8052433
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

  • 3. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M, Roszkowska-Blaim M.
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [Abstract] [Full Text] [Related]

  • 4. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M, Bartlett DK, Brier ME, Golper TA.
    Adv Perit Dial; 1993 Dec; 9():331-5. PubMed ID: 8105957
    [Abstract] [Full Text] [Related]

  • 5. The effect of high-flux hemodialysis on renal anemia.
    Ayli D, Ayli M, Azak A, Yüksel C, Kosmaz GP, Atilgan G, Dede F, Abayli E, Camlibel M.
    J Nephrol; 2004 Dec; 17(5):701-6. PubMed ID: 15593038
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Dec; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
    Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB.
    Nephrology (Carlton); 2006 Oct; 11(5):394-9. PubMed ID: 17014551
    [Abstract] [Full Text] [Related]

  • 12. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
    Barclay PG, Fischer ER, Harris DC.
    Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
    [Abstract] [Full Text] [Related]

  • 13. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S, Nasini MG, Santoni O, Tirotta A, Sanna A.
    ASAIO J; 1997 Mar; 43(5):M535-8. PubMed ID: 9360100
    [Abstract] [Full Text] [Related]

  • 16. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A, Gader AM, Huraib S, Mitwalli A, Al-Suleimani F, Al-Wakeel J.
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [Abstract] [Full Text] [Related]

  • 17. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
    Janicka L, Ksiazek A, Baranowicz I, Mierzicki P.
    Ann Univ Mariae Curie Sklodowska Med; 1994 Jun; 48 Suppl 3():67-77. PubMed ID: 8192534
    [Abstract] [Full Text] [Related]

  • 18. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A.
    Cochrane Database Syst Rev; 2002 Jun; (4):CD003895. PubMed ID: 12519614
    [Abstract] [Full Text] [Related]

  • 19. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D.
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [Abstract] [Full Text] [Related]

  • 20. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T.
    Scand J Urol Nephrol; 2003 Jul; 37(1):71-6. PubMed ID: 12745749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.